FibroGen Inc. [NASDAQ: FGEN] gained 6.49% on the last trading session, reaching $35.79 price per share at the time. FibroGen Inc. represents 88.22 million in outstanding shares, while the company has a total market value of $3.19 billion with the latest information. FGEN stock price has been found in the range of $33.10 to $36.1404.
If compared to the average trading volume of 743.34K shares, FGEN reached a trading volume of 2146313 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Get 12 free stock market lessons delivered to your email from Investor's Business Daily, the leader in investing education for over 35 years. We’ll cover the basics of better investing and show you how to give yourself an edge in the market.
GET FREE LESSON outside the norm.
Here is what top equities market gurus are saying about FibroGen Inc. [FGEN]:
Cowen have made an estimate for FibroGen Inc. shares, keeping their opinion on the stock as Market Perform, with their previous recommendation back on May 01, 2020. While these analysts kept the previous recommendation, BofA/Merrill raised their target price to Neutral. The new note on the price target was released on April 27, 2020, representing the official price target for FibroGen Inc. stock.
The Average True Range (ATR) for FibroGen Inc. is set at 2.02, with the Price to Sales ratio for FGEN stock in the period of the last 12 months amounting to 12.42. The Price to Book ratio for the last quarter was 6.88, with the Price to Cash per share for the same quarter was set at 6.00.
Trading performance analysis for FGEN stock
FibroGen Inc. [FGEN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.51. With this latest performance, FGEN shares dropped by -1.73% in over the last four-week period, additionally sinking by -24.48% over the last 6 months – not to mention a drop of -10.39% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for FGEN stock in for the last two-week period is set at 52.05, with the RSI for the last a single of trading hit 56.01, and the three-weeks RSI is set at 50.26 for FibroGen Inc. [FGEN]. The present Moving Average for the last 50 days of trading for this stock 36.17, while it was recorded at 33.59 for the last single week of trading, and 39.46 for the last 200 days.
FibroGen Inc. [FGEN]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and FibroGen Inc. [FGEN] shares currently have an operating margin of -34.81 and a Gross Margin at +91.19. FibroGen Inc.’s Net Margin is presently recorded at -30.00.
Return on Total Capital for FGEN is now -14.46, given the latest momentum, and Return on Invested Capital for the company is -13.01. Return on Equity for this stock declined to -15.01, with Return on Assets sitting at -8.86. When it comes to the capital structure of this company, FibroGen Inc. [FGEN] has a Total Debt to Total Equity ratio set at 12.32. Additionally, FGEN Total Debt to Total Capital is recorded at 10.97, with Total Debt to Total Assets ending up at 7.42. Long-Term Debt to Equity for the company is recorded at 9.74, with the Long-Term Debt to Total Capital now at 8.67.
Reflecting on the efficiency of the workforce at the company, FibroGen Inc. [FGEN] managed to generate an average of -$144,953 per employee. Receivables Turnover for the company is 2.36 with a Total Asset Turnover recorded at a value of 0.30.FibroGen Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 11.00 and a Current Ratio set at 11.10.
FibroGen Inc. [FGEN]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, FibroGen Inc. posted 1.26/share EPS, while the average EPS was predicted by analysts to be reported at -0.51/share.When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 347.10%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for FGEN.
An analysis of insider ownership at FibroGen Inc. [FGEN]
There are presently around $2,173 million, or 73.50% of FGEN stock, in the hands of institutional investors. The top three institutional holders of FGEN stocks are: FMR LLC with ownership of 9,809,447, which is approximately 3.978% of the company’s market cap and around 1.20% of the total institutional ownership; VANGUARD GROUP INC, holding 7,128,944 shares of the stock with an approximate value of $239.6 million in FGEN stocks shares; and BLACKROCK INC., currently with $235.79 million in FGEN stock with ownership of nearly 5.864% of the company’s market capitalization.
83 institutional holders increased their position in FibroGen Inc. [NASDAQ:FGEN] by around 6,887,688 shares. Additionally, 121 investors decreased positions by around 3,636,067 shares, while 38 investors held positions by with 54,125,744 shares. The mentioned changes placed institutional holdings at 64,649,499 shares, according to the latest SEC report filing. FGEN stock had 22 new institutional investments in for a total of 337,106 shares, while 46 institutional investors sold positions of 703,619 shares during the same period.